6.98
전일 마감가:
$7.26
열려 있는:
$7.27
하루 거래량:
1.52M
Relative Volume:
0.61
시가총액:
$2.59B
수익:
$9.47B
순이익/손실:
$-178.00M
주가수익비율:
-14.54
EPS:
-0.48
순현금흐름:
$1.01B
1주 성능:
-5.80%
1개월 성능:
+0.72%
6개월 성능:
+8.39%
1년 성능:
-8.76%
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
BHC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
BHC
Bausch Health Companies Inc
|
6.98 | 2.69B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
124.65 | 55.21B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
16.16 | 51.59B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.83 | 43.51B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
31.76 | 37.11B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
UTHR
United Therapeutics Corp
|
464.93 | 20.32B | 3.08B | 1.24B | 1.07B | 25.61 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Trend Report: Is Bausch Health Companies Inc backed by strong institutional buyingJuly 2025 EndofMonth & Growth Focused Entry Point Reports - baoquankhu1.vn
Bull Bear: Is Bausch Health Companies Inc showing insider buyingMarket Trend Report & Consistent Profit Alerts - baoquankhu1.vn
Loss Report: Whats the outlook for Bausch Health Companies Incs sectorJuly 2025 Momentum & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Bausch Health Companies (TSE:BHC) Trading Down 2.3%Here's What Happened - MarketBeat
Stop Loss: Is Bausch Health Companies Inc likely to announce a buybackMarket Movement Recap & Free High Return Stock Watch Alerts - baoquankhu1.vn
Bausch Health reaffirms 2025 outlook (BHC:NYSE) - Seeking Alpha
Bausch Health Brief: Management Expects to Reaffirm FY25 Guidance at Higher End of Range for Itself Excluding Bausch + Lomb As Provided In October - marketscreener.com
Bausch Health Companies Inc. (BHC) Stock Analysis: Exploring the 563.16% ROE and Future Potential - DirectorsTalk Interviews
Bausch Health Cos Inc. (NYSE:BHC) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Will Bausch Health Companies Inc. stock gain from green policiesWeekly Gains Summary & Entry Point Strategy Guides - Улправда
Is Bausch Health Companies Inc. stock cheap by valuation metricsJuly 2025 Update & Reliable Entry Point Trade Alerts - ulpravda.ru
Why Bausch Health Companies Stock Rocketed 11% Higher Today - MSN
Bausch Health: Solta’s Global Expansion Playbook Is Working—But Can China’s Slowdown Be Offset? - Smartkarma
How to contact the Daily Bulletin - FinancialContent
Bausch Health Cos Inc. $BHC Shares Sold by SG Americas Securities LLC - MarketBeat
Is Bausch Health Companies Inc. (BVF) stock a defensive play amid uncertaintyTreasury Yields & Daily Oversold Bounce Ideas - ulpravda.ru
Is Bausch Health Companies Inc. stock a safe haven assetGDP Growth & Fast Exit Strategy with Risk Control - ulpravda.ru
Will Bausch Health Companies Inc. stock continue dividend increasesJuly 2025 Institutional & Verified Technical Trade Signals - ulpravda.ru
Will Bausch Health Companies Inc. stock split again soonVolume Spike & Short-Term Trading Opportunity Alerts - ulpravda.ru
Why Bausch Health Companies Inc. stock is in analyst buy zoneRecession Risk & Free Safe Entry Trade Signal Reports - ulpravda.ru
Analysis Recap: Is Bausch Health Companies Inc. stock a safe haven assetJuly 2025 Outlook & Weekly Watchlist for Consistent Profits - ulpravda.ru
Eye Health Supplements Market 2026 Forecast: In-Depth Industry - openPR.com
Bausch Health Companies Inc. Common Stock (TSX: BHC - FinancialContent
Rally Mode: Is Bausch Health Companies Inc stock a safe haven assetWeekly Market Report & Daily Entry Point Trade Alerts - moha.gov.vn
Will Bausch Health Companies Inc. stock deliver shareholder valueMomentum Trading Signals & Today’s Picks, Tomorrow’s Winners - ulpravda.ru
Truist Securities Adjusts Price Target on Bausch Health to $8 From $7, Maintains Hold Rating - MarketScreener
Does Bausch Health (BHC) Extending Secured Debt to 2032 Clarify or Complicate Its Deleveraging Path? - simplywall.st
BHC Stock Price, Forecast & Analysis | BAUSCH HEALTH COS INC (NYSE:BHC) - Chartmill
Bausch Health Companies Inc. (BHC) Stock Analysis: A Closer Look at Its Potential in the Healthcare Sector - DirectorsTalk Interviews
A Look At Bausch Health (BHC) Valuation After Its US$1.6b Debt Refinancing - Sahm
Rosacea Market Research and Forecast Report 2025-2035: Galderma, AbbVie, Bausch Health, Journey Medical, and Sol-Gel Drive Innovation Through Expanded R&D and Clinical TrialsResearchAndMarkets.com - The AI Journal
Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference - The Globe and Mail
Trade Recap: Is Bausch Health Companies Inc stock overvalued by current metricsJuly 2025 EndofMonth & Verified Entry Point Signals - moha.gov.vn
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises - MSN
Bausch Health (NYSE: BHC) unit revises $2.8B term loans, extends 2028 debt to 2031 - Stock Titan
Bausch Health (BHC) director John Paulson discloses RSUs and large shareholdings - Stock Titan
Bausch Health (BHC) director reports 4,586 RSUs and 38,408 shares owned - Stock Titan
Bausch Health (BHC) director granted 989 RSUs as quarterly board compensation - Stock Titan
Looking Into Bausch Health Companies Inc's Recent Short Interest - Benzinga
Japan Dermatology Devices Market is Driven by Skin Health - openPR.com
Bausch Health Signs Multiple Material Agreements - TradingView — Track All Markets
Bausch Health (NYSE: BHC) swaps into $1.6B 10% 2032 secured notes - Stock Titan
BHC SEC FilingsBausch Health Companies Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Q2 EPS Estimate for Bausch Health Cos Boosted by Analyst - MarketBeat
What is Zacks Research's Estimate for TSE:BHC Q4 Earnings? - MarketBeat
Bausch Health (BHC) Is Up 5.3% After US$1.6 Billion Debt ExchangeHas The Bull Case Changed? - Yahoo Finance
Bausch Health announces completion of $1.6 billion debt exchange offer By Investing.com - Investing.com Nigeria
Bausch Health announces completion of $1.6 billion debt exchange offer - Investing.com
Bausch Health Announces Final Results and Expiration of Exchange Offers - ACCESS Newswire
Bausch Health Companies Inc Announces Final Results of Exchange Offers - TradingView — Track All Markets
Bausch Health Cos (NYSE:BHC) Trading Up 4.9%Time to Buy? - MarketBeat
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):